(Q39031764)

8 September 2017

1 reference

title

Hydroxychloroquine in systemic lupus erythematosus (SLE). (English)

1 reference

systemic lupus erythematosus

8 September 2017

0 references

0 references

author name string

C Ponticelli

series ordinal

1

1 reference

PubMed ID

27927040

8 September 2017

G Moroni

series ordinal

2

1 reference

PubMed ID

27927040

8 September 2017

language of work or name

English

0 references

publication date

7 December 2016

1 reference

Expert Opinion on Drug Safety

8 September 2017

1 reference

8 September 2017

16

1 reference

8 September 2017

3

1 reference

8 September 2017

411-419

1 reference

Multifaceted effects of hydroxychloroquine in human disease

8 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Lysosomal acidification mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

TFEB links autophagy to lysosomal biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Immunogenetics of systemic lupus erythematosus: A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Ultraviolet light and cutaneous lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Exposure to maternal smoking and incident SLE in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Programmed cell clearance: molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

The effect of cell death in the initiation of lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Interferon alpha in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

The pathogenesis of systemic lupus erythematosus—an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Interferon alpha as a primary pathogenic factor in human lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

T cells as therapeutic targets in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Altered B cell receptor signaling in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

BAFF and selection of autoreactive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Nanodomain coupling between Ca²⁺ channels and sensors of exocytosis at fast mammalian synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Unveiling the roles of autophagy in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

The Role of Autophagy in Lupus Nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Macroautophagy is deregulated in murine and human lupus T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Autophagy is activated in systemic lupus erythematosus and required for plasmablast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

RETRACTED ARTICLE: Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

The role of toll-like receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Inhibiting autophagy: a novel approach for the treatment of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Occasional series: lupus around the world systemic lupus erythematosus research in the Asia-Pacific region: a co-ordinated and co-operative approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Lupus erythematosus treated with a combination of quinacrine, hydroxychloroquine and chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Cutaneous lupus erythematosus: issues in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine: from malaria to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Biochemical characterization of ADP-ribose polymer metabolism in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Recognition and management of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine in lupus pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Pregnancy in women with systemic lupus erythematosus (SLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine, a promising choice for coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine: a multifaceted treatment in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

A possible early sign of hydroxychloroquine macular toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Chloroquine cardiomyopathy with conduction disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Chloroquine cardiomyopathy - a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Cardiomyopathy related to antimalarial therapy with illustrative case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Cutaneous Adverse Drug Reactions with Antimalarials and Allergological Skin Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Fatal toxic epidermal necrolysis associated with hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine-induced toxic myopathy causing respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Fulminant hepatic failure secondary to hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Abnormal weight gain and gut microbiota modifications are side effects of long-term doxycycline and hydroxychloroquine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Current role of rituximab in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

Epstein-Barr virus and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2017.1269168

10.1080/14740338.2017.1269168

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference

PubMed ID

27927040